Results 161 to 170 of about 38,942 (318)
Clinical Ophthalmology, 2013 Masahiro Miura,1,2 Takuya Iwasaki,1,2 Hiroshi Goto2 1Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, Ami, Ibaraki, Japan; 2Department of Ophthalmology, Tokyo Medical University, Nishi-Shinjuku, Tokyo, Japan Purpose: To ...
Miura M, Iwasaki T, Goto H
doaj
Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma [PDF]
, 2008 M‐H Song, Young‐Jung Roh
openalex +1 more source
Ophtalmologie. Rétinopathie diabétique: nouvelles possibilités thérapeutiques [Diabetic retinopathy: new therapeutic possibilities]. [PDF]
, 2015 La rétinopathie diabétique touche un nombre croissant de personnes, soit quatre millions en Europe, ce chiffre va probablement doubler d'ici 2030. Si l'on considère que 25-30% de ces patients sont atteints de rétinopathie diabétique, un dépistage et un ...
Behar-Cohen, F., Guex-Crosier, Y.
core
Resolution of retinal pigment epithelial detachment associated with exudative age‐related macular degeneration following intravitreal ranibizumab therapy [PDF]
, 2008 Vijay Khetpal +4 more
openalex +1 more source
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration
, 2007 Peter K. Kaiser
openalex +2 more sources
Effects of Intraocular Ranibizumab and Bevacizumab in Transgenic Mice Expressing Human Vascular Endothelial Growth Factor [PDF]
, 2009 Katsuaki Miki +5 more
openalex +1 more source
, 2016 Background: To investigate intravitreal treatment efficiencies in patients suffering from exudative ARMD with a BCVA ≤ 0.05. Methods: Retrospective analysis: Analysis parameters were lesion type, BCVA at baseline and at follow-up, the intravitreal drug ...
Busse, H. (Holger) +4 more
core +1 more source
Ranibizumab zur Behandlung der altersbedingten Makuladegeneration
, 2007 Sébastian Wolf
openalex +1 more source